Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. - Wikidata - wikimedia - TriplyDB

Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.

Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.

http://www.wikidata.org/entity/Q30490407

about

Genetic epidemiology of coronary artery disease: an Asian Indian perspective The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status.Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults.Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study.Associations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee.Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma.Stroke, IL-1ra, IL1RN, infection and outcome.A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock.Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits.Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach Poststroke fatigue: hints to a biological mechanism.Polymorphisms of interleukin-10 genes on the risk of ischemic stroke in a meta-analysis.Exploratory Cohort Study of Associations between Serum C - Reactive Protein and Fatigue after Stroke.Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection.Genome-wide associated loci influencing interleukin (IL)-10, IL-1Ra, and IL-6 levels in African Americans.Associations of interleukin-1 gene cluster polymorphisms with C-reactive protein concentration and lung function decline in smoking-induced chronic obstructive pulmonary disease Neonatal levels of acute phase proteins and later risk of non-affective psychosis.Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort.Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion.Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts.Interleukin-1 gene polymorphisms and chronic periodontitis in adult whites: a systematic review and meta-analysis.Inflammation and the Silent Sequelae of Stroke.An Association Between Functional Polymorphisms of the Interleukin 1 Gene Complex and Schizophrenia Using Transmission Disequilibrium Test.Polymorphisms in inflammation-related genes and the risk of primary varicose veins in ethnic Russians.Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes

P2860

Q26781807-81616805-B842-4F2A-9CEB-F679B1210611 Q28730838-148BBC59-C093-4632-BF5B-D8B70A4FBC64 Q33533455-12CAB891-502B-4A49-8C2C-CE0781F0D727 Q33561072-5675D01F-6C3A-4C87-9EA6-5265E6D3C62E Q33767339-DA165C18-C7A7-409E-98B1-CD8ACC8723A7 Q33932428-6FA4E5A7-DA3D-4E1C-9DC5-3DB6C422CE43 Q33946057-3A7E77C2-149E-4274-9A48-3F22A83B8905 Q34077678-198B28FD-7531-40A2-B31B-C6AAD0B202F7 Q34147463-2B12A960-BAFD-41C1-8541-8DA3362C1EB9 Q34164095-769E2182-EB53-492A-89EC-16A26767035B Q34425911-8117B034-E12D-480E-8EA0-6D0C3D92D1A6 Q34545454-BC29E4CD-781B-4D8B-BA9C-C1075D501236 Q35104849-D45C277D-1D01-4AE4-ACCE-268001B684AF Q35177506-31555F28-0532-4AF4-8E28-8955A11ED3F4 Q35479545-7121F1F0-DAB4-441B-BDAD-85B7BB537938 Q35849721-67311893-FE6B-4759-B7CB-ADE71F021F78 Q36043296-A91BD093-A711-4883-8E30-BF9E7803736D Q36161753-6D34DAF6-826A-4314-8ED2-417FE8B22557 Q36375338-03070B61-75A2-4EBF-AECA-B4C32380E459 Q36664739-3DF55854-DB42-4443-A55E-06E599ADB663 Q36762903-0D909348-9C90-4990-AF7B-F196DACF39C9 Q36999781-AA7CA1DD-CD1B-4A20-9385-F1B7307B8A75 Q37049661-6189FAA9-C67B-4C03-85B1-1BBC4B612881 Q37072366-F45ADE3C-680F-44CC-9CCA-3FA896ADD07A Q37148996-A6E94938-548A-4C09-9176-AD9F97A6F85B Q37319117-E14A7F79-81FD-4D25-990D-9E470090D841 Q37394589-D844592B-CC09-4797-80B9-AE42D9ABF05F Q37986227-D2D36746-57E3-4D88-92D0-DB17503796F4 Q38871034-6351B3F6-6CF4-481B-B394-5553588FD066 Q47829225-6A17A73B-DCE4-42F0-B0D2-6C00489226F5 Q48106919-0A454286-915E-49CD-93C1-9F59060D89BA Q56337838-D05D2D7F-069F-43EF-A2E9-AA6F5952CF75 Q57259837-25722042-1A3C-4484-A6A5-06D7304AC7E3

P2860

Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.

http://www.wikidata.org/entity/Q30490407

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Polymorphisms of the IL1-recep ...... kers of systemic inflammation.

@ast

Polymorphisms of the IL1-recep ...... kers of systemic inflammation.

@en

type

label

Polymorphisms of the IL1-recep ...... kers of systemic inflammation.

@ast

Polymorphisms of the IL1-recep ...... kers of systemic inflammation.

@en

prefLabel

Polymorphisms of the IL1-recep ...... kers of systemic inflammation.

@ast

Polymorphisms of the IL1-recep ...... kers of systemic inflammation.

@en

P1433

Q30490407-309F30C8-4B71-4C68-874D-879D226EBF84

P1476

Q30490407-56FE417E-77F3-45FB-B4A5-08D6D12744FE

P2093

Q30490407-103B84B6-F255-4EF1-A910-15516CD96653

Q30490407-2FF85BA4-2600-4C46-A495-D659BCA07797

Q30490407-485C6041-2A03-4E63-8611-FBADFA78262F

Q30490407-63A65D27-CF65-4D9D-AAE5-9367A043F514

Q30490407-645E5C55-C8BD-4A8C-ADB2-13D6DE90FE67

Q30490407-73A8A1A4-C616-44D6-8ABB-564C12BD17A9

Q30490407-8767124C-DC73-4387-8C64-6ACA7AC5AF2B

Q30490407-927ACD39-4060-4B8D-94FE-3DBA39DC004B

Q30490407-C446BDE6-F581-4CB8-8B60-B746D71C43F5

Q30490407-DBCF46ED-4CF0-488F-8A91-4B39FA56D380

P2860

Q30490407-05743C81-AAC6-4FFF-97EC-33710900AAE9

Q30490407-0A34027C-D80B-4B19-88CB-00D8A952B1F1

Q30490407-17330F36-C28B-474A-B140-DAE285E2EE37

Q30490407-1FC7F753-DF99-43C9-84E5-57EA1D5FF056

Q30490407-285404F9-516E-44AC-BC37-29CF8D6A96FF

Q30490407-29DB59BC-9FC1-4166-B9B7-5BECB9A8E4FA

Q30490407-34C9EC01-C8EC-4D77-9A66-C6578027D925

Q30490407-39C04169-DB76-4B71-8195-534E194B2F47

Q30490407-43A83BE6-0AD0-4F9D-B28D-D6E0B1D36C86

Q30490407-6D4C0EFC-41E3-4887-B1DF-27E9250CA288

P304

Q30490407-4FE14346-661F-44F7-9BAD-820357B9AD61

P31

Q30490407-FB3057E1-A6A8-4905-8540-C40FC1FFCEFA

Q30490407-def2c5e1-231b-4817-a711-21babbecd065

P356

Q30490407-81041406-A0B1-42BF-9208-16078F3348A3

P407

Q30490407-153C587E-E177-4F31-81D6-739B406D432B

P433

Q30490407-04486295-7E03-4F63-B21A-1CEB1BDC85C6

P478

Q30490407-88D33F06-8A93-4535-8921-F3C2D1F4288E

P50

Q30490407-B96185E3-D9E2-4763-B77C-FF4DE4DFF6B4

Q30490407-FD64C55D-601A-4A96-B6C5-FDA087F1CBB7

P577

Q30490407-7D0C9C5E-F0EA-4FA3-B715-74B48AE1D580

P698

Q30490407-5AAA306A-3DD9-4948-B88D-A88253847DE2

P921

Q30490407-F05147B2-6908-4B94-8F37-1CF887CCF03B

P932

Q30490407-DBBF9A42-389B-4EF9-955A-B6F9E75C6087

P356

ATVBAHA.108.167437

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Polymorphisms of the IL1-recep ...... kers of systemic inflammation.

@en

P2093

Alexander P Reiner

http://www.w3.org/2001/XMLSchema#string

Cara L Carty

http://www.w3.org/2001/XMLSchema#string

Carlos Iribarren

http://www.w3.org/2001/XMLSchema#string

Christopher S Carlson

http://www.w3.org/2001/XMLSchema#string

Cindy Desmarais

http://www.w3.org/2001/XMLSchema#string

Deborah A Nickerson

http://www.w3.org/2001/XMLSchema#string

Jeremy D Walston

http://www.w3.org/2001/XMLSchema#string

Leslie A Lange

http://www.w3.org/2001/XMLSchema#string

Mark J Rieder

http://www.w3.org/2001/XMLSchema#string

Mark M Wurfel

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase

PLINK: a tool set for whole-genome association and population-based linkage analyses

Meta-analysis in clinical trials

The balance between IL-1 and IL-1Ra in disease

Acute-phase proteins and other systemic responses to inflammation

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Imputation-based analysis of association studies: candidate regions and quantitative traits

Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.

A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

P304

1407-1412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.108.167437

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18451331

http://www.w3.org/2001/XMLSchema#string

P921

P932

2748384

http://www.w3.org/2001/XMLSchema#string